Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GSK GSK	$50.91 -0.2%	$54.47	$35.45 ▼ $61.69	$103.47B	0.38	4.24 million shs	3.53 million shs
MRK Merck & Co., Inc.	$113.21 -0.2%	$116.18	$73.31 ▼ $125.14	$280.20B	0.18	9.28 million shs	5.28 million shs
PFE Pfizer	$25.74 -0.8%	$27.01	$22.09 ▼ $28.75	$147.96B	0.35	37.21 million shs	24.05 million shs
RHHBY Roche	$51.29 +0.1%	$50.83	$35.07 ▼ $60.85	$326.55B	0.5	2.49 million shs	1.19 million shs
UNH UnitedHealth Group	$398.84 -0.6%	$314.78	$234.60 ▼ $404.15	$364.31B	0.64	8.53 million shs	5.34 million shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GSK GSK	-0.07%	+0.84%	-13.99%	-13.62%	+40.43%
MRK Merck & Co., Inc.	-0.32%	+0.87%	-5.62%	-6.74%	+54.10%
PFE Pfizer	-0.83%	-2.78%	-5.12%	-6.65%	+16.95%
RHHBY Roche	+0.06%	+1.39%	+0.51%	-12.34%	+37.36%
UNH UnitedHealth Group	-0.46%	+7.90%	+26.90%	+35.97%	+29.35%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GSK GSK	$50.91 -0.2%	$54.47	$35.45 ▼ $61.69	$103.47B	0.38	4.24 million shs	3.53 million shs
MRK Merck & Co., Inc.	$113.21 -0.2%	$116.18	$73.31 ▼ $125.14	$280.20B	0.18	9.28 million shs	5.28 million shs
PFE Pfizer	$25.74 -0.8%	$27.01	$22.09 ▼ $28.75	$147.96B	0.35	37.21 million shs	24.05 million shs
RHHBY Roche	$51.29 +0.1%	$50.83	$35.07 ▼ $60.85	$326.55B	0.5	2.49 million shs	1.19 million shs
UNH UnitedHealth Group	$398.84 -0.6%	$314.78	$234.60 ▼ $404.15	$364.31B	0.64	8.53 million shs	5.34 million shs

Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GSK GSK	-0.07%	+0.84%	-13.99%	-13.62%	+40.43%
MRK Merck & Co., Inc.	-0.32%	+0.87%	-5.62%	-6.74%	+54.10%
PFE Pfizer	-0.83%	-2.78%	-5.12%	-6.65%	+16.95%
RHHBY Roche	+0.06%	+1.39%	+0.51%	-12.34%	+37.36%
UNH UnitedHealth Group	-0.46%	+7.90%	+26.90%	+35.97%	+29.35%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
GSK GSK	1.90	Reduce	$53.00	4.11% Upside
MRK Merck & Co., Inc.	2.68	Moderate Buy	$128.18	13.23% Upside
PFE Pfizer	2.23	Hold	$28.84	12.05% Upside
RHHBY Roche	2.45	Hold	$51.50	0.41% Upside
UNH UnitedHealth Group	2.72	Moderate Buy	$378.88	-5.00% Downside

Current Analyst Ratings Breakdown

Latest GSK, UNH, MRK, PFE, and RHHBY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/14/2026	PFE Pfizer	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Underperform	$26.00
5/7/2026	UNH UnitedHealth Group	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (D+) ➝ Hold (C-)
5/6/2026	PFE Pfizer	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C-) ➝ Hold (C)
5/6/2026	MRK Merck & Co., Inc.	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Neutral	$125.00
5/1/2026	GSK GSK	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold (C+) ➝ Buy (B)
5/1/2026	MRK Merck & Co., Inc.	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold (C+)
5/1/2026	MRK Merck & Co., Inc.	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Overweight	$150.00 ➝ $145.00
4/29/2026	PFE Pfizer	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$26.00 ➝ $27.00
4/28/2026	UNH UnitedHealth Group	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$389.00 ➝ $420.00
4/27/2026	UNH UnitedHealth Group	Erste Group Bank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Buy
4/24/2026	RHHBY Roche	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Underweight ➝ Equal Weight	$46.00

(Data available from 5/15/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
GSK GSK	$43.07B	2.40	$6.00 per share	8.49	$11.57 per share	4.40
MRK Merck & Co., Inc.	$65.01B	4.30	$11.40 per share	9.93	$18.60 per share	6.09
PFE Pfizer	$62.58B	2.34	$4.36 per share	5.90	$15.86 per share	1.62
RHHBY Roche	$76.45B	4.27	$3.60 per share	14.24	$7.18 per share	7.14
UNH UnitedHealth Group	$447.57B	0.81	$21.14 per share	18.87	$114.40 per share	3.49

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
GSK GSK	$7.54B	$3.85	13.23	9.90	2.60	17.82%	44.28%	11.49%	7/29/2026 (Estimated)
MRK Merck & Co., Inc.	$18.25B	$3.55	31.89	11.59	2.55	13.59%	27.55%	10.73%	N/A
PFE Pfizer	$7.77B	$1.31	19.65	9.00	N/A	11.83%	19.44%	8.41%	N/A
RHHBY Roche	$15.55B	N/A	N/A	14.61	4.22	N/A	N/A	N/A	7/23/2026 (Estimated)
UNH UnitedHealth Group	$12.06B	$13.24	30.12	19.39	1.73	2.68%	14.65%	4.77%	N/A

Latest GSK, UNH, MRK, PFE, and RHHBY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
5/5/2026	Q1 2026	PFE Pfizer	$0.7220	$0.75	+$0.0280	$0.47	$13.84 billion	$14.45 billion
4/30/2026	Q1 2026	MRK Merck & Co., Inc.	-$1.47	-$1.28	+$0.19	-$1.72	$15.85 billion	$16.29 billion
4/21/2026	Q1 2026	UNH UnitedHealth Group	$6.76	$7.23	+$0.47	$6.90	$109.84 billion	$111.65 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
GSK GSK	$1.88	3.69%	-7.86%	48.83%	N/A
MRK Merck & Co., Inc.	$3.40	3.00%	+5.75%	95.77%	14 Years
PFE Pfizer	$1.72	6.68%	-13.20%	131.30%	16 Years
RHHBY Roche	$0.97	1.89%	N/A	N/A	N/A
UNH UnitedHealth Group	$8.84	2.22%	+12.57%	66.77%	15 Years

Latest GSK, UNH, MRK, PFE, and RHHBY Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/29/2026	GSK GSK	quarterly	$0.44	3.62%	5/15/2026	5/15/2026	7/9/2026
4/22/2026	PFE Pfizer	quarterly	$0.43	6.71%	5/8/2026	5/8/2026	6/12/2026
2/24/2026	UNH UnitedHealth Group	quarterly	$2.21	3.1%	3/9/2026	3/9/2026	3/17/2026
1/1/2100	GSK GSK	quarterly	$0.4206	4.3%	8/15/2025	8/15/2025	10/9/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
GSK GSK	0.80	0.79	0.52
MRK Merck & Co., Inc.	1.02	1.30	1.06
PFE Pfizer	0.67	1.25	0.94
RHHBY Roche	0.72	1.38	1.12
UNH UnitedHealth Group	0.69	0.80	0.80

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
GSK GSK	15.74%
MRK Merck & Co., Inc.	76.07%
PFE Pfizer	68.36%
RHHBY Roche	N/A
UNH UnitedHealth Group	87.86%

Insider Ownership

Company	Insider Ownership
GSK GSK	10.00%
MRK Merck & Co., Inc.	0.17%
PFE Pfizer	0.62%
RHHBY Roche	N/A
UNH UnitedHealth Group	0.28%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
GSK GSK	66,841	2.03 billion	1.83 billion	Optionable
MRK Merck & Co., Inc.	75,000	2.47 billion	2.47 billion	Optionable
PFE Pfizer	75,000	5.70 billion	5.66 billion	Optionable
RHHBY Roche	103,249	6.37 billion	N/A	Not Optionable
UNH UnitedHealth Group	390,000	908.14 million	905.60 million	Optionable

GSK, UNH, MRK, PFE, and RHHBY Headlines

Recent News About These Companies

Phoenix Financial Ltd. Grows Position in UnitedHealth Group Incorporated $UNH

51 minutes ago | marketbeat.com

Tejara Capital Ltd Makes New $3.53 Million Investment in UnitedHealth Group Incorporated $UNH

51 minutes ago | marketbeat.com

UnitedHealth Group Incorporated $UNH Shares Sold by Thrivent Financial for Lutherans

59 minutes ago | marketbeat.com

Promising Healthcare Stocks To Research - May 13th

2 hours ago | americanbankingnews.com

Medical Stocks To Keep An Eye On - May 13th

2 hours ago | americanbankingnews.com

Bessemer Group Inc. Sells 126,707 Shares of UnitedHealth Group Incorporated $UNH

3 hours ago | marketbeat.com

Conning Inc. Has $34.39 Million Stake in UnitedHealth Group Incorporated $UNH

3 hours ago | marketbeat.com

AustralianSuper Pty Ltd Acquires 139,849 Shares of UnitedHealth Group Incorporated $UNH

4 hours ago | marketbeat.com

UnitedHealth: TrumpRx Is A Nothingburger

May 14 at 12:05 AM | seekingalpha.com

Dow Closes Above 50,000 for First Time in Months

May 14 at 8:45 PM | finance.yahoo.com

Forget UnitedHealth: Two Stocks To Buy Now

May 14 at 1:13 PM | 247wallst.com

UnitedHealth: Beaten Down, Not Broken

May 14 at 12:01 PM | seekingalpha.com

Cardinal Health Was Supposed to Beat UnitedHealth. Did It? Will It?

May 14 at 11:05 AM | 247wallst.com

Here's Why UnitedHealth Group (UNH) is a Strong Momentum Stock

May 14 at 10:51 AM | zacks.com

Investors Heavily Search UnitedHealth Group Incorporated (UNH): Here is What You Need to Know

May 14 at 10:01 AM | zacks.com

VIRGINIA RETIREMENT SYSTEMS ET Al Reduces Stock Position in UnitedHealth Group Incorporated $UNH

May 14 at 7:22 AM | marketbeat.com

Pacer Advisors Inc. Lowers Position in UnitedHealth Group Incorporated $UNH

May 14 at 5:46 AM | marketbeat.com

Summit Wealth Group LLC Co. Decreases Holdings in UnitedHealth Group Incorporated $UNH

May 14 at 5:38 AM | marketbeat.com

UnitedHealth Group Incorporated $UNH Shares Sold by Bank Julius Baer & Co. Ltd Zurich

May 14 at 4:22 AM | marketbeat.com

Promising Medical Stocks To Watch Now - May 12th

May 14 at 4:07 AM | americanbankingnews.com

Top Healthcare Stocks To Keep An Eye On - May 12th

May 14 at 4:07 AM | americanbankingnews.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

GSK, UNH, MRK, PFE, and RHHBY Company Descriptions

GSK NYSE:GSK

$50.91 -0.08 (-0.16%)

Closing price 05/14/2026 03:59 PM Eastern

Extended Trading

$50.07 -0.84 (-1.64%)

As of 07:23 AM Eastern

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled medicines for asthma and chronic obstructive pulmonary disease, and antibiotics for infections. It has a collaboration agreement with CureVac to develop mRNA-based influenza vaccines, and with Wave Life Sciences and Elsie Biotechnologies, Inc for oligonucleotide platform development. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.

Merck & Co., Inc. NYSE:MRK

$113.20 -0.25 (-0.22%)

Closing price 05/14/2026 03:59 PM Eastern

Extended Trading

$113.06 -0.14 (-0.13%)

As of 07:31 AM Eastern

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Pfizer NYSE:PFE

$25.74 -0.22 (-0.85%)

Closing price 05/14/2026 03:59 PM Eastern

Extended Trading

$25.76 +0.02 (+0.08%)

As of 07:30 AM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Roche OTCMKTS:RHHBY

$51.29 +0.03 (+0.06%)

As of 05/14/2026 03:59 PM Eastern

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.

UnitedHealth Group NYSE:UNH

$398.84 -2.32 (-0.58%)

Closing price 05/14/2026 03:59 PM Eastern

Extended Trading

$391.84 -7.00 (-1.76%)

As of 07:31 AM Eastern

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest GSK, UNH, MRK, PFE, and RHHBY Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest GSK, UNH, MRK, PFE, and RHHBY Earnings

Compare Dividends

Latest GSK, UNH, MRK, PFE, and RHHBY Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

GSK, UNH, MRK, PFE, and RHHBY Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

GSK, UNH, MRK, PFE, and RHHBY Company Descriptions

GSK NYSE:GSK

Merck & Co., Inc. NYSE:MRK

Pfizer NYSE:PFE

Roche OTCMKTS:RHHBY

UnitedHealth Group NYSE:UNH

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools